Edwards Lifesciences (EW) Income from Non-Controlling Interests (2023 - 2026)

Edwards Lifesciences has reported Income from Non-Controlling Interests for 4 years, with the latest figure at -$500000.0 in Q2 2026.

• On a quarterly basis, Income from Non-Controlling Interests rose 70.59% year-over-year to -$500000.0 in Q2 2026; TTM through Jun 2026 was -$1.3 million, a 78.33% increase from a year earlier, with the FY2025 full-year figure at -$4.1 million, up 16.33% from the prior year.
• Income from Non-Controlling Interests was -$500000.0 for Q2 2026 at Edwards Lifesciences, up from -$800000.0 in the prior quarter.
• The five-year high for Income from Non-Controlling Interests was -$200000.0 in Q4 2023, with the low at -$1.7 million in Q2 2025.
• Average Income from Non-Controlling Interests over 4 years is -$1.1 million, with a median of -$1.3 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Income from Non-Controlling Interests tumbled 550.0% in 2024, then surged 70.59% in 2026.
• Over 4 years, Income from Non-Controlling Interests stood at -$200000.0 in 2023, then sank by 550.0% to -$1.3 million in 2024, then jumped by 38.46% to -$800000.0 in 2025, then soared by 37.5% to -$500000.0 in 2026.
• The last three Income from Non-Controlling Interests figures came in at -$500000.0 (Q2 2026), -$800000.0 (Q3 2025), and -$1.7 million (Q2 2025), per Business Quant data.